Clinical trial

Prevention of Asthma and Allergy by Probiotic Lactobacillus GG

NCT00490425 · Johann Wolfgang Goethe University Hospital, Other · Completed

Key facts

NCT number NCT00490425
Title Prevention of Asthma and Allergy by Probiotic Lactobacillus GG
Official title Efficacy of Lactbacillus GG on Wheeze and Allergic Sensitization in Infants at Risk
Acronym FRALAC
Lead sponsor Johann Wolfgang Goethe University Hospital, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Allergic Asthma
Intervention type Drug
Interventions Lactobacillus rhamnosus strain GG ATCC 53103 (LGG, 1010 cfu)
Enrollment 131
Start date Oct 1, 2002
Completion Oct 1, 2006
First posted Jun 22, 2007
Last update posted Jun 22, 2007
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies